Roger Schutgens
Roger Schutgens
UMC Utrecht
Geverifieerd e-mailadres voor umcutrecht.nl - Homepage
Geciteerd door
Geciteerd door
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ...
Journal of Thrombosis and Haemostasis 10 (4), 622-631, 2012
Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
W Miesbach, K Meijer, M Coppens, P Kampmann, R Klamroth, ...
Blood, The Journal of the American Society of Hematology 131 (9), 1022-1031, 2018
Clinical severity of haemophilia A: does the classification of the 1950s still stand?
IEM Den Uijl, EP Mauser Bunschoten, G Roosendaal, REG Schutgens, ...
Haemophilia 17 (6), 849-853, 2011
Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis
REG Schutgens, P Ackermark, F Haas, HK Nieuwenhuis, HG Peltenburg, ...
Circulation 107 (4), 593-597, 2003
Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis
GJ Geersing, NPA Zuithoff, C Kearon, DR Anderson, AJ Ten Cate-Hoek, ...
Bmj 348, 2014
How I treat age-related morbidities in elderly persons with hemophilia
PM Mannucci, REG Schutgens, E Santagostino, EP Mauser-Bunschoten
Blood, The Journal of the American Society of Hematology 114 (26), 5256-5263, 2009
Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level
MJ Agterof, REG Schutgens, RJ Snijder, G Epping, HG Peltenburg, ...
Journal of Thrombosis and Haemostasis 8 (6), 1235-1241, 2010
Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled …
M Teraa, RW Sprengers, REG Schutgens, ICM Slaper-Cortenbach, ...
Circulation 131 (10), 851-860, 2015
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
J Leentjens, TF Van Haaps, PF Wessels, REG Schutgens, S Middeldorp
The Lancet Haematology 8 (7), e524-e533, 2021
Age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded
RA Douma, M Tan, R Schutgens, SM Bates, A Perrier, C Legnani, ...
haematologica 97 (10), 1507-1513, 2012
Co‐morbidity in the ageing haemophilia patient: the down side of increased life expectancy
EP Mauser‐Bunschoten, DE Fransen Van De Putte, REG Schutgens
Haemophilia 15 (4), 853-863, 2009
Cardiovascular disease in patients with hemophilia
A Tuinenburg, EP Mauser‐Bunschoten, MC Verhaar, DH Biesma, ...
Journal of Thrombosis and Haemostasis 7 (2), 247-254, 2009
Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study
NS GIBSON, SM SCHELLONG, DYE Kheir, J Beyer‐Westendorf, ...
Journal of Thrombosis and Haemostasis 7 (12), 2035-2041, 2009
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ...
Jama 326 (17), 1690-1702, 2021
Pathophysiology of hemophilic arthropathy and potential targets for therapy
AE Pulles, SC Mastbergen, REG Schutgens, FPJG Lafeber, ...
Pharmacological research 115, 192-199, 2017
The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis
RE Schutgens, MM Beckers, FJ Haas, DH Biesma
haematologica 90 (2), 214-219, 2005
Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline
REG Schutgens, A Tuinenburg, G Roosendaal, SH Guyomi, ...
Haemophilia 15 (4), 952-958, 2009
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
KPM van Galen, ET Engelen, EP Mauser‐Bunschoten, RJJ van Es, ...
Cochrane Database of Systematic Reviews, 2019
Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment
G Roosendaal, NWD Jansen, R Schutgens, F Lafeber
Haemophilia 14, 4-10, 2008
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study …
KM van Nieuwenhuizen, HB van der Worp, A Algra, LJ Kappelle, ...
Trials 16 (1), 1-12, 2015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20